Figures & data
Table 1 Demographic data of the MDD patients and healthy controls
Table 2 Relations between HAM-DI7 sub-items scores and IL-6, MHPG, or HVA
Table 3 Comparison of IL-6 between the MDD patients and HC
Table 4 The raw correlations among the biological measures
Table 5 The adjusted correlations among the biological measures
Table 6 Calculated power for three biomarkers
Figure 1 Dot plot of IL-6 between MDD and HC (P=0.00096).
![Figure 1 Dot plot of IL-6 between MDD and HC (P=0.00096).](/cms/asset/65f6d961-27fa-48a2-9105-6d2cfe88bbfc/dndt_a_195379_f0001_b.jpg)
Figure 2 Partial regression residual leverage plot of plasma IL-6 levels and HAM-D17 scores (P<0.0001, RCitation2=0.33).
![Figure 2 Partial regression residual leverage plot of plasma IL-6 levels and HAM-D17 scores (P<0.0001, RCitation2=0.33).](/cms/asset/bf80cc59-0c39-4232-824a-158fdd6c6289/dndt_a_195379_f0002_c.jpg)
Figure 3 Partial regression residual leverage plot of plasma MHPGlevels and HAM-D17 scores (P=0.8630).
![Figure 3 Partial regression residual leverage plot of plasma MHPGlevels and HAM-D17 scores (P=0.8630).](/cms/asset/bbc6078f-c6c8-4656-bc1b-fac239fea083/dndt_a_195379_f0003_c.jpg)
Figure 4 Partial regression residual leverage plot of plasma HVAlevels and HAM-D17 scores (P=0.9860).
![Figure 4 Partial regression residual leverage plot of plasma HVAlevels and HAM-D17 scores (P=0.9860).](/cms/asset/73feebe3-f039-4cf2-b6ab-08d2df3156d0/dndt_a_195379_f0004_c.jpg)